Outset Medical (OM) Cash & Current Investments (2018 - 2026)

Outset Medical (OM) has 9 years of Cash & Current Investments data on file, last reported at $286.6 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $286.6 million, up 51.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $286.6 million (up 51.66% YoY), and the FY2025 annual result was $168.9 million, up 6.47% from the prior year.
• Cash & Current Investments improved to $286.6 million in Q1 2026 per OM's latest filing, from $168.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $331.9 million in Q2 2025 and troughed at $158.7 million in Q4 2024.
• A 5-year average of $236.6 million and a median of $227.5 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2025: Cash & Current Investments slumped 39.01% in 2022, then soared 81.16% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $290.8 million in 2022, then dropped by 28.94% to $206.7 million in 2023, then retreated by 23.21% to $158.7 million in 2024, then gained by 6.47% to $168.9 million in 2025, then surged by 69.67% to $286.6 million in 2026.
• Business Quant data shows OM's Cash & Current Investments at $286.6 million in Q1 2026, $168.9 million in Q4 2025, and $324.2 million in Q3 2025.